News › Industry News, News

BTL Files Complaint with ITC to Prevent Unlawful Importation of Body Contouring Products

August 7, 2020

BTL Industries, Inc., the manufacturer of the Emsculpt body-contouring device and other products for non-invasive body-shaping procedures, has filed a complaint with the United States International Trade Commission (ITC) asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company (Allergan), and Zimmer MedizinSysteme GmbH, Germany (Zimmer) from importing products that infringe BTL’s patents into the United States. BTL concurrently filed a lawsuit with the U.S. Federal District Court in the District of Delaware against Allergan and Zimmer on the same matter.
The ITC is an independent, quasi-judicial federal agency with broad investigative responsibilities on matters that affect trade and commerce, including intellectual property infringement.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
    • Galderma Receives EU Approval for Restylane Shaype: Bone-Mimicking Hyaluronic Acid Injectable for Chin
    • Merz Aesthetics’ Ultherapy PRIME Gains FDA Clearance for Knee Skin Laxity
    • USA Payments Becomes Gold Vendor Affiliate with the American Med Spa Association
    • CVS, Eli Lilly Expand Consumer Access to GLP-1 Weight Loss Medications
Advertisement